fda approved tirzepatide approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly FDA Announces End of Tirzepatide

Studies show neuroprotective effects in Alzheimer's and Parkinson's disease models through reduced inflammation, enhanced neuronal survival, and improved cognitive function

Semaglutide results broken down honestly what 15%, 20%, and 30% body weight loss looks like in real numbers, real clothes sizes, and real energy levels.

This milestone reflects a closely integrated development-to-submission model, with Orbicular leading product development and OneSource supporting the program as the CDMO partner for manufacturing and supply readiness

This review explores the therapeutic potential of GLP-1 RAs in AS, summarising pre-clinical and clinical data and elucidating the pathways through which GLP-1 RAs might offer renoprotective benefits

These are still early findings

Orbicular Pharmaceutical Technologies, in partnership with Apotex Inc., announces the launch of generic Semaglutide Injection in Canada